Alembic Pharmaceuticals Limited

NSEI:APLLTD Voorraadrapport

Marktkapitalisatie: ₹220.9b

Alembic Pharmaceuticals Dividend

Dividend criteriumcontroles 4/6

Alembic Pharmaceuticals is a dividend paying company with a current yield of 0.98% that is well covered by earnings.

Belangrijke informatie

1.0%

Dividendrendement

n/a

Terugkoop Rendement

Totaal aandeelhoudersrendementn/a
Toekomstig dividendrendement1.5%
Dividendgroei6.9%
Volgende betaaldatum dividendn/a
Ex-dividenddatumn/a
Dividend per aandeel₹11.000
Uitbetalingsratio35%

Recente dividendupdates

Recent updates

Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price

Sep 25
Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price

Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?

Sep 03
Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?

Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 13
Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher

Jul 20
Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher

Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly

Jun 03
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly

Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?

May 11
Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?

Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 08
Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%

Jan 21
Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%

Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Jan 05
Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly

Sep 27
Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly

Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly

Jun 09
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly

A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Apr 13
A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Feb 22
Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate

Jan 04
Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now

Nov 05
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now

Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden

Aug 10
Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Jul 20
Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

We Think Alembic Pharmaceuticals (NSE:APLLTD) Is Taking Some Risk With Its Debt

May 05
We Think Alembic Pharmaceuticals (NSE:APLLTD) Is Taking Some Risk With Its Debt

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: APLLTD's dividend payments have been volatile in the past 10 years.

Groeiend dividend: APLLTD's dividend payments have increased over the past 10 years.


Dividendrendement versus markt

Alembic Pharmaceuticals Dividendrendement versus markt
Hoe verhoudt APLLTD dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (APLLTD)1.0%
Markt onderkant 25% (IN)0.2%
Markt Top 25% (IN)1.1%
Gemiddelde industrie (Pharmaceuticals)0.7%
Analist prognose (APLLTD) (tot 3 jaar)1.5%

Opmerkelijk dividend: APLLTD's dividend (0.98%) is higher than the bottom 25% of dividend payers in the Indian market (0.24%).

Hoog dividend: APLLTD's dividend (0.98%) is low compared to the top 25% of dividend payers in the Indian market (1.09%).


Winstuitkering aan aandeelhouders

Verdiendekking: With its reasonably low payout ratio (35.1%), APLLTD's dividend payments are well covered by earnings.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: With its reasonably low cash payout ratio (45.5%), APLLTD's dividend payments are well covered by cash flows.


Ontdek bedrijven met een sterk dividend